Skip to content

Clinical trials

Neoplasms by Site trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Taiwan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20142
20161
20174
20192
20201
20214
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Blueprint Medicines Corporation2
Eli Lilly and Company2
Hoffmann-La Roche2
Revolution Medicines, Inc.2
Sumitomo Pharma America, Inc.2
AVEO Pharmaceuticals, Inc.1
Abbott1
Astellas Pharma Global Development, Inc.1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site22
Neoplasms20
Carcinoma, Non-Small-Cell Lung11
Lung Neoplasms11
Lung Diseases10
Respiratory Tract Diseases10
Respiratory Tract Neoplasms10
Adenocarcinoma9
Bronchial Neoplasms9
Carcinoma9

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.